A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa

PHASE4CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

August 31, 2009

Primary Completion Date

April 30, 2010

Study Completion Date

April 30, 2010

Conditions
Non-small Cell Lung Cancer
Interventions
GENETIC

EGFR Mutation Test

Explore the EGFR mutation status from both tumour tissue sample and the free DNA in the peripheral blood using appropriate method(s) which may include ARMS assay, ME-PCR coupled sequencing and regular sequencing.

GENETIC

Ki-67 protein expression

Ki-67 protein expression in tissue will be analysed by IHC method.

Trial Locations (9)

Unknown

Research Site, Beijing

Research Site, Guangzhou

Research Site, Wuhan

Research Site, Nanjing

Research Site, Suzhou

Research Site, Jinan

Research Site, Shanghai

Research Site, Chengdu

Research Site, Hangzhou

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY